Blood cancers, Lymphoma, Non-Hodgkin lymphoma (NHL)
Open
Phase 2
This study is looking at an drug called mogamulizumab with .
It is for people with a type of lymphoma that started in the of the skin (cutaneous T cell lymphoma) called mycosis fungoides.
It is for people who have had at least one type of treatment that reached the whole body (systemic), and their lymphoma has either:
come back or
got worse
Recruitment start: 27 February 2023
Recruitment end: 31 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Julia Scarisbrick
European Organisation for Research and Treatment of Cancer (EORTC)
Last reviewed: 29 Aug 2025
CRUK internal database number: 19161
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
